Treatment outcome correlates with knowledge of disease in hemifacial spasm

Clinical Neurology and Neurosurgery

Volumn 110, Issue 8, 2008, Pages 813-817

  Tan, Eng King ^a,b   Hameed, Shahul ^a   Fook Chong, S ^a   Hussein, Khadijah ^a   Lum, Sau Ying ^a   Chan, Ling Ling ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Botulinum toxin; Hemifacial spasm; Knowledge; Quality of life

Indexed keywords

BOTULINUM TOXIN;

ACADEMIC ACHIEVEMENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEMIFACIAL SPASM; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRE; TREATMENT OUTCOME;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTI-DYSKINESIA AGENTS; BOTULINUM TOXINS; FEMALE; HEMIFACIAL SPASM; HUMANS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 49749135741     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2008.05.010     Document Type: Article

References (22)

1. Tan N.C., Chan L.L., and Tan E.K. Hemifacial spasm and involuntary facial movements. QJM 95 8 (2002) 493-500
2. Wang A., and Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve 21 (1998) 1-8
3. Ho S.L., Cheng P.W., Wong W.C., Chan F.L., Lo S.K., Li L.S., et al. A case-controlled MRI/MRA study of neurovascular contact in hemifacial spasm. Neurology 53 9 (1999) 2132-2139
4. Chan L.L., Lo Y.L., Lee E., Fook-Chong S., and Tan E.K. Ventrolateral medullary compression in hypertensive patients with hemifacial spasm. Neurology 65 9 (2005) 1467-1470
5. Tan E.K., and Jankovic J. Bilateral hemifacial spasm: report of five cases and a literature review. Mov Disord 14 (1999) 345-349
6. Tan E.K., Chan L.L., and Koh K.K. Coexistent blepharospasm and hemifacial spasm: overlapping pathophysiologic mechanism?. J Neurol Neurosurg Psychiatry 75 3 (2004) 494-496
7. Auger R.G., and Whisnant J.P. Hemifacial spasm in Rochester and Olmstead County, Minnesota, 1960 to 1984. Arch Neurol 47 (1990) 1233-1234
8. Tan E.K., Fook-Chong S., Lum S.Y., and Thumboo J. Validation of a short disease specific quality of life scale for hemifacial spasm: correlation with SF-36. J Neurol Neurosurg Psychiatry 76 12 (2005) 1707-1710
9. Heuser K., Kerty E., Eide P.K., Cvancarova M., and Dietrichs E. Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality. Eur J Neurol 14 3 (2007) 335-340
10. Tan E.K., Fook-Chong S., Lum S.Y., and Lim E. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30). J Neurol Sci 219 1-2 (2004) 151-155
11. Scheidt C.E., Schuller B., Rayki O., Kommerell G., and Deuschl G. Relative absence of psychopathology in benign essential blepharospasm and hemifacial spasm. Neurology 47 1 (1996) 43-45
12. Tan E.K., Fook-Chong S., and Lum S.Y. Case-control study of anxiety symptoms in hemifacial spasm. Mov Disord 21 12 (2006) 2145-2149
13. Tan E.K., Lum S.Y., Fook-Chong S., Chan L.L., Gabriel C., and Lim L. Behind the facial twitch: depressive symptoms in hemifacial spasm. Parkinsonism Relat Disord 11 4 (2005) 241-245
14. Jankovic J., Schwartz K., and Donovan D.T. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53 (1990) 633-639
15. Tan E.K., and Jankovic J. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology 53 9 (1999) 2102-2107
16. Sui X, Gheorghiade M, Zannad F, Young JB, Ahmed A. A propensity matched study of the association of education and outcomes in chronic heart failure. Int J Cardiol 2007; July 20 [Epub ahead of print].
17. Stephens D, Kentala E, Varpa K, Pyykko I. Positive experiences associated With Meniere's disorder. Otol Neurotol 2007; July 14 [Epub ahead of print].
18. Larsson K., Sundberg Hjelm M., Karlbom U., Nordin K., Anderberg U.M., and Loof L. A group-based patient education programme for high-anxiety patients with Crohn disease or ulcerative colitis. Scand J Gastroenterol 38 7 (2003) 763-769
19. Tan E.K., Lee J., Hunter C., Shinawi L., Fook-Chong S., and Jankovic J. Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population. J Neurol Sci 252 2 (2007) 113-120
20. Kenney C, Jankovic J. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neural Transm 2007; June 11 [Epub ahead of print].
21. Truong D.D., and Jost W.H. Botulinum toxin: clinical use. Parkinsonism Relat Disord 12 6 (2006) 331-355
22. Defazio G., Abbruzzese G., Girlanda P., et al. Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study. Arch Neurol 59 3 (2002) 418-420